Expressive Helping for Stem Cell Transplant Patients

NCT03800758 · Status: COMPLETED · Phase: PHASE3 · Type: INTERVENTIONAL · Enrollment: 405

Last updated 2023-05-06

No results posted yet for this study

Summary

The Writing for Insight, Strength, and Ease (WISE) Study is a multisite Randomized Controlled Trial (RCT) testing the efficacy of the Expressive Helping (EH) intervention among adults receiving hematopoietic stem cell transplantation.

Conditions

  • Stem Cell Transplantation
  • Hematologic Malignancy

Interventions

BEHAVIORAL

Expressive Helping

Expressive Helping (EH) is completed in 4 brief structured writing sessions during and immediately after transplant, with instructions focused on having participants write about their transplant experience using previously-tested EH instructions, adapted for this population.

BEHAVIORAL

Factual Writing

Factual Writing has been used with cancer patients and in the investigators' prior EH trial. It is completed in 4 brief structured writing sessions during and immediately after transplant, with instructions focused on having participants write about their transplant experience using standard Factual Writing instructions.

Sponsors & Collaborators

  • National Cancer Institute (NCI)

    collaborator NIH
  • Lombardi Comprehensive Cancer Center

    collaborator OTHER
  • Hackensack Meridian Health

    collaborator OTHER
  • Northwestern University

    lead OTHER

Study Design

Allocation
RANDOMIZED
Purpose
SUPPORTIVE_CARE
Masking
SINGLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2019-03-06
Primary Completion
2023-04-24
Completion
2023-04-24

Countries

  • United States

Study Locations

More Related Trials

Entities

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03800758 on ClinicalTrials.gov